August 31, 2024Open Access

A multi-centre randomised controlled trial comparing megestrol acetate to levonorgestrel-intrauterine system in fertility sparing treatment of atypical endometrial hyperplasia

Key Points

Key points are not available for this paper at this time.

Abstract

The objective of the trial was to compare the regression rate of atypical endometrial hyperplasia (AEH) in patients treated with megestrol acetate (MA) vs. levonorgestrel-intrauterine device (LNG-IUS). We also aimed to assess the fertility and pregnancy outcomes in these patients.

Read Full Paperexternally

Demander à l'IA

Bookmark

View Full Paper

Cite This Study

Goh et al. (Sat,) studied this question.

synapsesocial.com/papers/68e5a0adb6db64358753b8ef https://doi.org/https://doi.org/10.1007/s10815-024-03172-z

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia2006 · 602 citations
2Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia2016 · 61 citations
3Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis2014 · 223 citations
4International Patterns and Trends in Endometrial Cancer Incidence, 1978–20132017 · 794 citations
5Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia2023 · 86 citations

Demander à l'IA

Bookmark

View Full Paper